TRILINK BIOTECHNOLOGIES, LLC

Trilink Biotechnologies, LLC specializes in the development and manufacturing of custom nucleic acid-based reagents and diagnostic substances, with deep expertise in mRNA synthesis, phosphorylated oligonucleotide production, and cleanroom-grade reagent formulation. The company delivers precision-engineered molecular tools for in-vitro diagnostics, supporting advanced research and clinical applications through GMP-aligned processes. Their technical proficiency spans solid-phase oligo synthesis, chemical modification of nucleic acids, and scalable production of sequence-specific RNA constructs, enabling high-purity, low-contamination outputs critical for diagnostic assay integrity and regulatory compliance. Trilink’s differentiation lies in its ability to rapidly prototype and manufacture bespoke molecular reagents under tightly controlled conditions, serving as a mission-critical partner for agencies requiring reliable, non-commodity biochemical components. The company maintains a consistent relationship with the Department of Health and Human Services, providing specialized diagnostic reagents and custom synthesis services that support public health research and diagnostic development initiatives. It also delivers targeted molecular solutions to the Environmental Protection Agency, indicating engagement in environmental health and toxicology applications requiring highly specific nucleic acid probes or molecular standards. Trilink’s primary focus is in in-vitro diagnostic substance manufacturing and testing laboratory services, positioning it as a niche supplier within the molecular diagnostics and life sciences research ecosystem. The firm serves vertical markets requiring custom oligonucleotides, modified RNA, and validated reagent kits—areas where off-the-shelf solutions are insufficient for complex assay development or regulatory submissions. As a small business entity structured under 2K, Trilink operates from its base in San Diego, California, leveraging proximity to biotech innovation hubs. While currently holding no formal government certifications, its technical rigor and consistent delivery of mission-critical biochemical materials establish a strong reputation within federal science and health programs.